SEC Form 4 · accession 0001209191-15-075530
CORCEPT THERAPEUTICS INC · CORT
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Steven Lo
Officer — VP Commercial Operations
Period of report
Oct 13, 2015
Accepted (ET)
Oct 15, 2015 · 11:49 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001088856
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common stockF1 | Oct 13, 2015 | S | 53,033 | $3.82 | D | 0 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1Price shown is the average price. Price of the individual blocks sold ranged from $3.80 to $3.85 per share.